Answers are grounded in this paper and cite their sources.
Demonstrates improved severity prediction in acute pancreatitis using a deep learning model, suggesting enhanced management strategies.
Background Acute pancreatitis (AP) is a common gastrointestinal disease with a rising global incidence. While most cases are mild, severe AP (SAP) carries high mortality. Early and accurate severity prediction facilitates management optimization. However, existing clinical severity prediction models, such as Bedside Index of Severity in Acute Pancreatitis (BISAP) and Modified CT Severity Index (mCTSI), have modest accuracy and often rely on data unavailable at admission. Purpose This study proposes a deep learning (DL) model to predict AP severity using abdominal contrast-enhanced CT (CECT) scans acquired within 24 hours of admission. Materials and Methods We collected 10,130 studies from 8,335 patients across a multi-site U.S. health system and 3,488 studies from public datasets. The DL model was trained in two stages: (1) self-supervised pretraining on 11,896 unlabeled studies and (2) fine-tuning on 550 labeled studies. Performance was evaluated against mCTSI on a hold-out internal test set (n = 100 patients) and against both mCTSI and BISAP on an external Hungarian acute pancreatitis registry (n = 518 patients). Results On the internal test set, the model achieved AUROCs of 0.888 (95% CI: 0.800–0.960, sensitivity 0.50, specificity 0.92) for SAP and 0.888 (95% CI: 0.819–0.946, sensitivity 0.75, specificity 0.85) for mild AP (MAP), outperforming mCTSI (p = 0.002). External validation showed AUROCs of 0.887 (95% CI: 0.825–0.941, sensitivity 0.73, specificity 0.88) for SAP and 0.858 (95% CI: 0.826–0.888, sensitivity 0.38, specificity 0.98) for MAP, surpassing mCTSI (p = 0.024) and BISAP (p = 0.002). In retrospective triage analysis, the model correctly identified 50–73% of patients who progressed to SAP and 40–73% of those with MAP. Conclusion The proposed DL model achieved performance comparable to or better than established prognostic tools and maintained robust external performance. These findings suggest that AI-assisted CT analysis may support early, automated risk stratification of AP.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: